Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Taxus Liberte cardiovascular data

In the ATLAS Small Vessel study, Taxus Liberte showed superiority to BMS (45.6% vs. 32.1%;

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE